Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in IndiaThomas Bollyky
Apr. 14, 2013
1.The Huffington Post Is What Happens When There's No Men In The Room
2.Hungary PM: Clinton is George Soros Puppet, Wants to Overrun EU With Millions of Muslims
3.Angry Birds Movie is Red-Pilled Anti-Immigration Propaganda
4.LA Senate Passes Total Gun Ban After Radical Muslims They Let In Killed People
5.The Guardian's Steven Thrasher Plays Victim After His Anti-White Hate Video Goes Viral
6.The Guardian: 'Revolution' Possible in 2043 When Whites Become Minority in U.S.
7.You Won't Believe Michelle Fields' Brilliant Advice to the Hillary Campaign
8.WATCH: Germany's New Right Leader Schools Brainwashed Young Leftists
Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?
It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India.